Search details
1.
Modeling human somite development and fibrodysplasia ossificans progressiva with induced pluripotent stem cells.
Development
; 145(16)2018 08 23.
Article
in English
| MEDLINE | ID: mdl-30139810
2.
Neofunction of ACVR1 in fibrodysplasia ossificans progressiva.
Proc Natl Acad Sci U S A
; 112(50): 15438-43, 2015 Dec 15.
Article
in English
| MEDLINE | ID: mdl-26621707
3.
New Protocol to Optimize iPS Cells for Genome Analysis of Fibrodysplasia Ossificans Progressiva.
Stem Cells
; 33(6): 1730-42, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25773749
4.
Oxidative phosphorylation is a pivotal therapeutic target of fibrodysplasia ossificans progressiva.
Life Sci Alliance
; 7(5)2024 May.
Article
in English
| MEDLINE | ID: mdl-38365425
5.
A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
J Exp Med
; 221(6)2024 Jun 03.
Article
in English
| MEDLINE | ID: mdl-38652464
6.
Automated cell culture system for the production of cell aggregates with growth plate-like structure from induced pluripotent stem cells.
SLAS Technol
; 28(6): 433-441, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37562511
7.
Collagen X Is Dispensable for Hypertrophic Differentiation and Endochondral Ossification of Human iPSC-Derived Chondrocytes.
JBMR Plus
; 7(5): e10737, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37197316
8.
3D osteogenic differentiation of human iPSCs reveals the role of TGFß signal in the transition from progenitors to osteoblasts and osteoblasts to osteocytes.
Sci Rep
; 13(1): 1094, 2023 01 19.
Article
in English
| MEDLINE | ID: mdl-36658197
9.
Recapitulation of pro-inflammatory signature of monocytes with ACVR1A mutation using FOP patient-derived iPSCs.
Orphanet J Rare Dis
; 17(1): 364, 2022 09 21.
Article
in English
| MEDLINE | ID: mdl-36131296
10.
Bio-3D printing iPSC-derived human chondrocytes for articular cartilage regeneration.
Biofabrication
; 13(4)2021 08 25.
Article
in English
| MEDLINE | ID: mdl-34380122
11.
Differentiation of Hypertrophic Chondrocytes from Human iPSCs for the In Vitro Modeling of Chondrodysplasias.
Stem Cell Reports
; 16(3): 610-625, 2021 03 09.
Article
in English
| MEDLINE | ID: mdl-33636111
12.
Prophylactic treatment of rapamycin ameliorates naturally developing and episode -induced heterotopic ossification in mice expressing human mutant ACVR1.
Orphanet J Rare Dis
; 15(1): 122, 2020 05 24.
Article
in English
| MEDLINE | ID: mdl-32448372
13.
In vitro bone-like nodules generated from patient-derived iPSCs recapitulate pathological bone phenotypes.
Nat Biomed Eng
; 3(7): 558-570, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31182836
14.
An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
Stem Cell Reports
; 11(5): 1106-1119, 2018 11 13.
Article
in English
| MEDLINE | ID: mdl-30392977
15.
Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva.
J Clin Invest
; 127(9): 3339-3352, 2017 Sep 01.
Article
in English
| MEDLINE | ID: mdl-28758906
16.
SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier.
PLoS One
; 10(11): e0142991, 2015.
Article
in English
| MEDLINE | ID: mdl-26571495
17.
Mutant IDH1 Dysregulates the Differentiation of Mesenchymal Stem Cells in Association with Gene-Specific Histone Modifications to Cartilage- and Bone-Related Genes.
PLoS One
; 10(7): e0131998, 2015.
Article
in English
| MEDLINE | ID: mdl-26161668
18.
Derivation of mesenchymal stromal cells from pluripotent stem cells through a neural crest lineage using small molecule compounds with defined media.
PLoS One
; 9(12): e112291, 2014.
Article
in English
| MEDLINE | ID: mdl-25464501
Results
1 -
18
de 18
1
Next >
>>